Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.

Experts recommend starting systemic treatment for alopecia areata when the condition is severe or causes significant distress.

Alopecia areata in elderly people is usually mild and responds well to treatment.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Adult acne severity is influenced by stress, skin sensitivity, makeup, stopping oral contraceptives, and requires female-specific treatment guidelines.

Skin emergency severity rises with other health issues and affects multiple organs; a new grading system can improve patient care.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Histopathology is not reliable for detecting early fibrosis in traction alopecia or for showing how severe it is.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Some vitamins and minerals like vitamin D and iron can help with certain types of hair loss, but more research is needed for others.

JAK inhibitors effectively improve hair regrowth in alopecia areata with an acceptable safety profile.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

People with alopecia areata often have lower vitamin D levels than healthy people.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Trichoscopy is better than the hair pull test for tracking alopecia areata.

No link between scalp patterns and alopecia severity in children, but more severe cases often had nail abnormalities.

New dermoscopic criteria accurately diagnose and grade the severity of hair loss in androgenetic alopecia.

The criteria help doctors diagnose and treat alopecia areata more effectively.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

Most people in Turkey start getting gray hair around 33 years old, with factors like age, education, hair loss, skin type, family history, and anxiety playing a role.

Premature hair graying in young men is linked to family history, obesity, and smoking.

Premature hair graying in young Turkish adults is more likely if they have stress, a family history of graying, drink alcohol, have chronic diseases, are older, or are taller.

People with Alopecia areata often have lower Vitamin D levels, which might affect the severity of their condition.

Both atopy and eosinophilia are linked to more severe hair loss in people with alopecia areata.

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.